Table 4 Genotype frequencies of the SNPs and their associations with risk of endometrial cancer
From: Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk
SNP | Model | Genotype | Case | Control | Without adjustment | With adjustment of age | ||
|---|---|---|---|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | |||||
rs118050317 | Co-dominant | GG | 268 | 282 | 1 | 1 | ||
CG | 74 | 61 | 1.28 (0.87–1.86) | 0.206 | 1.28 (0.88–1.87) | 0.202 | ||
CC | 8 | 1 | 8.42 (1.05–67.76) | 0.045* | 8.43 (1.05–67.89) | 0.045* | ||
Dominant | GG | 268 | 282 | 1 | 1 | |||
CG + CC | 82 | 62 | 1.39 (0.96–2.01) | 0.080 | 1.40 (0.96–2.02) | 0.078 | ||
Recessive | GG + CG | 342 | 343 | 1 | 1 | |||
CC | 8 | 1 | 8.02 (1.00–64.50) | 0.050 | 8.03 (1.00–64.52) | 0.050 | ||
Log-additive | – | – | – | 1.46 (1.04–2.06) | 0.029* | 1.47 (1.04–2.07) | 0.029* | |